- Reuters•2 days ago
Alexion Pharmaceuticals Inc on Monday named former Baxalta CEO Ludwig Hantson to its top job, as the rare-disease drug maker seeks to regain investor confidence following the exit of top management. Hantson's appointment comes after a challenging few months for the U.S. biotech. Alexion's flagship drug Soliris, which treats two rare blood disorders, has fueled much of the company's growth, but looming competition and the drug's slowing sales growth in recent quarters have made investors jittery.
- Business Wire•7 days ago
Baxter International Inc. to Host First Quarter 2017 Financial Results Conference Call for Investors
Baxter International Inc. , will host a quarterly conference call to discuss its first quarter 2017 financial results on Wednesday, April 26, 2017, at 7:30 a.m. Central Standard Time.
BAX : Summary for Baxter International Inc. Commo - Yahoo Finance
Baxter International Inc. (BAX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||51.56 - 52.19|
|52 Week Range||40.52 - 52.33|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||5.77|
|Dividend & Yield||0.52 (1.00%)|
|1y Target Est||N/A|